{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:37:00Z","timestamp":1768253820438,"version":"3.49.0"},"reference-count":104,"publisher":"Bentham Science Publishers Ltd.","issue":"19","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Neurodegenerative disorders are a group of diseases that cause\nnerve cell degeneration in the brain, resulting in a variety of symptoms and are not treatable\nwith drugs. Parkinson's disease (PD), prion disease, motor neuron disease (MND),\nHuntington's disease (HD), spinal cerebral dyskinesia (SCA), spinal muscle atrophy (SMA),\nmultiple system atrophy, Alzheimer's disease (AD), spinocerebellar ataxia (SCA)\n(ALS), pantothenate kinase-related neurodegeneration, and TDP-43 protein disorder are\nexamples of neurodegenerative diseases. Dementia is caused by the loss of brain and spinal\ncord nerve cells in neurodegenerative diseases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Even though environmental and genetic predispositions have also been involved\nin the process, redox metal abuse plays a crucial role in neurodegeneration since\nthe preponderance of symptoms originates from abnormal metal metabolism.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>Hence, this review investigates several neurodegenerative diseases that may occur\nsymptoms similar to Parkinson's disease to understand the differences and similarities\nbetween Parkinson's disease and other neurodegenerative disorders based on reviewing\npreviously published papers.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Based on the findings, the aggregation of alpha-synuclein occurs in Parkinson\u2019s\ndisease, multiple system atrophy, and dementia with Lewy bodies. Other neurodegenerative\ndiseases occur with different protein aggregation or mutations<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>We can conclude that Parkinson's disease, Multiple system atrophy, and Dementia\nwith Lewy bodies are closely related. Therefore, researchers must distinguish\namong the three diseases to avoid misdiagnosis of Multiple System Atrophy and Dementia\nwith Lewy bodies with Parkinson's disease symptoms.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867330666230403085733","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T04:48:02Z","timestamp":1680670082000},"page":"2770-2787","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An Update on Parkinson\u2019s Disease and its Neurodegenerative\nCounterparts"],"prefix":"10.2174","volume":"31","author":[{"given":"Hussaini","family":"Adam","sequence":"first","affiliation":[{"name":"Institute of Nano Electronic Engineering, Universiti Malaysia Perlis (UniMAP), 01000, Kangar, Perlis,\nMalaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subash C.B.","family":"Gopinath","sequence":"additional","affiliation":[{"name":"Faculty of Chemical Engineering &amp; Technology, Universiti Malaysia Perlis (UniMAP), 02600,\nArau, Perlis, Malaysia"},{"name":"Institute of Nano Electronic Engineering, Universiti Malaysia Perlis (UniMAP), 01000, Kangar, Perlis,\nMalaysia"},{"name":"Micro System Technology, Centre of Excellence (CoE), Universiti Malaysia Perlis\n(UniMAP), Pauh Campus, 02600, Arau, Perlis, Malaysia"},{"name":"Centre for Chemical Biology (CCB), Universiti\nSains Malaysia, Bayan Lepas, 11900 Penang, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.K. Md","family":"Arshad","sequence":"additional","affiliation":[{"name":"Institute of Nano Electronic Engineering, Universiti Malaysia Perlis (UniMAP), 01000, Kangar, Perlis,\nMalaysia"},{"name":"Faculty of Electronic Engineering &amp; Technology,\nUniversiti Malaysia Perlis (UniMAP), Pauh Campus, 02600 Arau, Perlis, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tijjani","family":"Adam","sequence":"additional","affiliation":[{"name":"Institute of Nano Electronic Engineering, Universiti Malaysia Perlis (UniMAP), 01000, Kangar, Perlis,\nMalaysia"},{"name":"Faculty of Electronic Engineering &amp; Technology,\nUniversiti Malaysia Perlis (UniMAP), Pauh Campus, 02600 Arau, Perlis, Malaysia"},{"name":"Micro System Technology, Centre of Excellence (CoE), Universiti Malaysia Perlis\n(UniMAP), Pauh Campus, 02600, Arau, Perlis, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreeramanan","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"School of Biological\nSciences, Universiti Sains Malaysia, Georgetown, 11800 Penang, Malaysia"},{"name":"Faculty of Chemical Engineering &amp; Technology, Universiti Malaysia Perlis (UniMAP), 02600,\nArau, Perlis, Malaysia"},{"name":"Centre for Chemical Biology (CCB), Universiti\nSains Malaysia, Bayan Lepas, 11900 Penang, Malaysia"},{"name":"National Poison Centre, Universiti\nSains Malaysia (USM), Georgetown, 11800, Penang, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uda","family":"Hashim","sequence":"additional","affiliation":[{"name":"Institute of Nano Electronic Engineering, Universiti Malaysia Perlis (UniMAP), 01000, Kangar, Perlis,\nMalaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neurol.2020.03.017","volume":"176","author":"Teissier T.","year":"2020","unstructured":"Teissier T.; Boulanger E.; Deramecourt V.; Normal ageing of the brain: Histological and biological aspects. Rev Neurol  2020,176(9),649-660","journal-title":"Rev Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"Dugger B.N.","year":"2017","unstructured":"Dugger B.N.; Dickson D.W.; Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol  2017,9(7),a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-022-00524-0","volume":"17","author":"Wareham L.K.","year":"2022","unstructured":"Wareham L.K.; Liddelow S.A.; Temple S.; Benowitz L.I.; Di Polo A.; Wellington C.; Goldberg J.L.; He Z.; Duan X.; Bu G.; Davis A.A.; Shekhar K.; Torre A.L.; Chan D.C.; Canto-Soler M.V.; Flanagan J.G.; Subramanian P.; Rossi S.; Brunner T.; Bovenkamp D.E.; Calkins D.J.; Solving neurodegeneration: Common mechanisms and strategies for new treatments. Mol Neurodegener  2022,17(1),23","journal-title":"Mol Neurodegener"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/antiox9080647","volume":"9","author":"Picca A.","year":"2020","unstructured":"Picca A.; Calvani R.; Coelho-J\u00fanior H.J.; Landi F.; Bernabei R.; Marzetti E.; Mitochondrial dysfunction, oxidative stress, and neuroinflammation: Intertwined roads to neurodegeneration. Antioxidants  2020,9(8),647","journal-title":"Antioxidants"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","volume":"5","author":"Deture M.A.","year":"2019","unstructured":"Deture M.A.; Dickson D.W.; The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener  2019,5,1-8","journal-title":"Mol Neurodegener"},{"key":"ref=6","first-page":"1","author":"Gustavsson A.","year":"2022","unstructured":"Gustavsson A.; Norton N.; Fast T.; Fr\u00f6lich L.; Georges J.; Holzapfel D.; Kirabali T.; Krolak-Salmon P.; Rossini P.M.; Ferretti M.T.; Lanman L.; Chadha A.S.; van der Flier W.M.; Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimers Dement  2022,1-13","journal-title":"Alzheimers Dement"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-1027-y","volume":"15","author":"Wilkaniec A.","year":"2018","unstructured":"Wilkaniec A.; G\u0105ssowska-Dobrowolska M.; Strawski M.; Adamczyk A.; Czapski G.A.; Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity. J Neuroinflammation  2018,15(1),1-18","journal-title":"J Neuroinflammation"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"17373","DOI":"10.18632\/oncotarget.14538","volume":"8","author":"Shupp A.","year":"2017","unstructured":"Shupp A.; Casimiro M.C.; Pestell R.G.; Biological functions of CDK5 and potential CDK5 targeted clinical treatments. Oncotarget  2017,8(10),17373-17382","journal-title":"Oncotarget"},{"key":"ref=9","author":"Zahoor I.","year":"2018","unstructured":"Zahoor I.; Shafi A.; Haq E.;  Parkinson\u2019s disease (Book)  2018","journal-title":"Parkinson\u2019s disease (Book)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/mdc3.12784","volume":"6","author":"McKay J.L.","year":"2019","unstructured":"McKay J.L.; Hackney M.E.; Factor S.A.; Ting L.H.; Lower limb rigidity is associated with frequent falls in Parkinson\u2019s disease. Mov Disord Clin Pract  2019,6(6),446-451","journal-title":"Mov Disord Clin Pract"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/biom5020865","volume":"5","author":"Emanuele M.","year":"2015","unstructured":"Emanuele M.; Chieregatti E.; Mechanisms of alpha-synuclein action on neurotransmission: Cell-autonomous and non-cell autonomous role. Biomolecules  2015,5(2),865-892","journal-title":"Biomolecules"},{"key":"ref=12","first-page":"12","author":"Novellino F.","year":"2022","unstructured":"Novellino F.; Salsone M.; Riccelli R.; Chiriaco C.; Argir\u00f2 G.; Quattrone A.; Madrigal J.L.M.; Ferini Strambi L.; Quattrone A.;  Connectivity Alterations in Vascular Parkinsonism: A Structural Covariance Study  2022,12","journal-title":"Connectivity Alterations in Vascular Parkinsonism: A Structural Covariance Study"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"38070","DOI":"10.1038\/srep38070","volume":"6","author":"Son S.J.","year":"2016","unstructured":"Son S.J.; Kim M.; Park H.; Imaging analysis of Parkinson\u2019s disease patients using SPECT and tractography. Sci Rep  2016,6(1),38070","journal-title":"Sci Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"673395","DOI":"10.3389\/fcell.2021.673395","volume":"9","author":"Ray B.","year":"2021","unstructured":"Ray B.; Mahalakshmi A.M.; Tuladhar S.; Bhat A.; Srinivasan A.; Pellegrino C.; Kannan A.; Bolla S.R.; Chidambaram S.B.; Sakharkar M.K.; \u201cJanus-faced\u201d \u03b1-synuclein: Role in Parkinson\u2019s disease. Front Cell Dev Biol  2021,9,673395","journal-title":"Front Cell Dev Biol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2169\/naika.86.1262","volume":"86","author":"Nishida N.","year":"1997","unstructured":"Nishida N.; Miyamoto T.; Prion disease. Nippon Naika Gakkai Zasshi  1997,86(7),1262-1268","journal-title":"Nippon Naika Gakkai Zasshi"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40478-019-0735-1","volume":"7","author":"Hartmann K.","year":"2019","unstructured":"Hartmann K.; Sepulveda-Falla D.; Rose I.V.L.; Madore C.; Muth C.; Matschke J.; Butovsky O.; Liddelow S.; Glatzel M.; Krasemann S.; Complement 3-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia. Acta Neuropathol Commun  2019,7(1),83","journal-title":"Acta Neuropathol Commun"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12883-016-0751-8","volume":"16","author":"Dirzius E.","year":"2016","unstructured":"Dirzius E.; Balnyte R.; Steibliene V.; Gleizniene R.; Gudinaviciene I.; Radziunas A.; Petrikonis K.; Sporadic Creutzfeldt-Jakob disease with unusual initial presentation as posterior reversible encephalopathy syndrome: A case report. BMC Neurol  2016,16(1),234","journal-title":"BMC Neurol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.3390\/ijms20143606","volume":"20","author":"Bernardi L.","year":"2019","unstructured":"Bernardi L.; Bruni A.C.; Mutations in prion protein gene: Pathogenic mechanisms in c-terminal vs. n-terminal domain, a review. Int J Mol Sci  2019,20(14),3606","journal-title":"Int J Mol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e3000725","DOI":"10.1371\/journal.pbio.3000725","volume":"18","author":"Asante E.A.","year":"2020","unstructured":"Asante E.A.; Linehan J.M.; Tomlinson A.; Jakubcova T.; Hamdan S.; Grimshaw A.; Smidak M.; Jeelani A.; Nihat A.; Mead S.; Brandner S.; Wadsworth J.D.F.; Collinge J.; Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS. PLoS Biol  2020,18(6),e3000725","journal-title":"PLoS Biol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"Brown P.","year":"2012","unstructured":"Brown P.; Brandel J.P.; Sato T.; Nakamura Y.; MacKenzie J.; Will R.G.; Ladogana A.; Pocchiari M.; Leschek E.W.; Schonberger L.B.; Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis  2012,18(6),901-907","journal-title":"Emerg Infect Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/biom10020290","volume":"10","author":"Llorens F.","year":"2020","unstructured":"Llorens F.; Villar-Piqu\u00e9 A.; Hermann P.; Schmitz M.; Calero O.; Stehmann C.; Sarros S.; Moda F.; Ferrer I.; Poleggi A.; Pocchiari M.; Catania M.; Klotz S.; O\u2019Regan C.; Brett F.; Heffernan J.; Ladogana A.; Collins S.J.; Calero M.; Kovacs G.G.; Zerr I.; Diagnostic accuracy of prion disease biomarkers in iatrogenic creutzfeldt-jakob disease. Biomolecules  2020,10(2),290","journal-title":"Biomolecules"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41582-021-00488-7","volume":"17","author":"Watson N.","year":"2021","unstructured":"Watson N.; Brandel J.P.; Green A.; Hermann P.; Ladogana A.; Lindsay T.; Mackenzie J.; Pocchiari M.; Smith C.; Zerr I.; Pal S.; The importance of ongoing international surveillance for Creutzfeldt\u2013Jakob disease. Nat Rev Neurol  2021,17(6),362-379","journal-title":"Nat Rev Neurol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"Rudd K.E.","year":"2020","unstructured":"Rudd K.E.; Johnson S.C.; Agesa K.M.; Shackelford K.A.; Tsoi D.; Kievlan D.R.; Colombara D.V.; Ikuta K.S.; Kissoon N.; Finfer S.; Fleischmann-Struzek C.; Machado F.R.; Reinhart K.K.; Rowan K.; Seymour C.W.; Watson R.S.; West T.E.; Marinho F.; Hay S.I.; Lozano R.; Lopez A.D.; Angus D.C.; Murray C.J.L.; Naghavi M.; Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet  2020,395(10219),200-211","journal-title":"Lancet"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","volume":"20","author":"Hermann P.","year":"2021","unstructured":"Hermann P.; Appleby B.; Brandel J.P.; Caughey B.; Collins S.; Geschwind M.D.; Green A.; Ha\u00efk S.; Kovacs G.G.; Ladogana A.; Llorens F.; Mead S.; Nishida N.; Pal S.; Parchi P.; Pocchiari M.; Satoh K.; Zanusso G.; Zerr I.; Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol  2021,20(3),235-246","journal-title":"Lancet Neurol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3390\/ijms22042196","volume":"22","author":"Li B.","year":"2021","unstructured":"Li B.; Chen M.; Zhu C.; Neuroinflammation in prion disease. Int J Mol Sci  2021,22(4),2196","journal-title":"Int J Mol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fnins.2019.00532","volume":"13","author":"Ragagnin A.M.G.","year":"2019","unstructured":"Ragagnin A.M.G.; Shadfar S.; Vidal M.; Jamali M.S.; Atkin J.D.; Motor neuron susceptibility in ALS\/FTD. Front Neurosci  2019,13,532","journal-title":"Front Neurosci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s10072-021-05188-0","volume":"42","author":"De Marchi F.","year":"2021","unstructured":"De Marchi F.; Carrarini C.; De Martino A.; Diamanti L.; Fasano A.; Lupica A.; Russo M.; Salemme S.; Spinelli E.G.; Bombaci A.; Cognitive dysfunction in amyotrophic lateral sclerosis: Can we predict it? Neurol Sci  2021,42(6),2211-2222","journal-title":"Neurol Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fnins.2019.00951","volume":"13","author":"Benbrika S.","year":"2019","unstructured":"Benbrika S.; Desgranges B.; Eustache F.; Viader F.; Cognitive, emotional and psychological manifestations in amyotrophic lateral sclerosis at baseline and overtime: A review. Front Neurosci  2019,13,951","journal-title":"Front Neurosci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3389\/fgene.2019.01092","volume":"10","author":"Potter H.","year":"2019","unstructured":"Potter H.; Chial H.J.; Caneus J.; Elos M.; Elder N.; Borysov S.; Granic A.; Chromosome instability and mosaic aneuploidy in neurodegenerative and neurodevelopmental disorders. Front Genet  2019,10,1092","journal-title":"Front Genet"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"ddw286","DOI":"10.1093\/hmg\/ddw286","volume":"25","author":"Shin J.W.","year":"2016","unstructured":"Shin J.W.; Kim K.H.; Chao M.J.; Atwal R.S.; Gillis T.; MacDonald M.E.; Gusella J.F.; Lee J.M.; Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9. Hum Mol Genet  2016,25(20),ddw286","journal-title":"Hum Mol Genet"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.31887\/DCNS.2016.18.1\/pnopoulos","volume":"18","author":"Nopoulos P.C.","year":"2016","unstructured":"Nopoulos P.C.; Huntington disease: A single-gene degenerative disorder of the striatum. Dialogues Clin Neurosci  2016,18(1),91-98","journal-title":"Dialogues Clin Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1212\/WNL.0000000000002874","volume":"87","author":"Delatycki M.B.","year":"2016","unstructured":"Delatycki M.B.; Bandmann O.; Huntington disease. Neurology  2016,87(3),247-248","journal-title":"Neurology"},{"key":"ref=33","first-page":"1","author":"Caron N.S.","year":"2019","unstructured":"Caron N.S.; Wright G.E.B.; Hayden M.R.; Frcp C.;  Huntington Disease Summary Suggestive Findings  2019,1-34","journal-title":"Huntington Disease Summary Suggestive Findings"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JHD-180341","volume":"8","author":"Ready R.E.","year":"2019","unstructured":"Ready R.E.; Boileau N.R.; Barton S.K.; Lai J.S.; McCormack M.K.; Cella D.; Fritz N.E.; Paulsen J.S.; Carlozzi N.E.; Positive affect and well-being in Huntington\u2019s disease moderates the association between functional impairment and HRQOL outcomes. J Huntingtons Dis  2019,8(2),221-232","journal-title":"J Huntingtons Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/brainsci12101389","volume":"12","author":"Irfan Z.","year":"2022","unstructured":"Irfan Z.; Khanam S.; Karmakar V.; Firdous S.M.; El Khier B.S.I.A.; Khan I.; Rehman M.U.; Khan A.; Pathogenesis of Huntington\u2019s disease: An emphasis on molecular pathways and prevention by natural remedies. Brain Sci  2022,12(10),1389","journal-title":"Brain Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1212\/WNL.0000000000008699","volume":"94","author":"Feustel A.C.","year":"2020","unstructured":"Feustel A.C.; MacPherson A.; Fergusson D.A.; Kieburtz K.; Kimmelman J.; Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease. Neurology  2020,94(1),e1-e14","journal-title":"Neurology"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JAD-179901","volume":"64","author":"Cummings J.","year":"2018","unstructured":"Cummings J.; Ritter A.; Zhong K.; Clinical trials for disease-modifying therapies in Alzheimer\u2019s disease: A primer, lessons learned, and a blueprint for the future. J Alzheimers Dis  2018,64(s1),S3-S22","journal-title":"J Alzheimers Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s13311-019-00823-3","volume":"16","author":"Ellerby L.M.","year":"2019","unstructured":"Ellerby L.M.; Repeat expansion disorders: Mechanisms and therapeutics. Neurotherapeutics  2019,16(4),924-927","journal-title":"Neurotherapeutics"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fnins.2020.00892","volume":"14","author":"Park J.Y.","year":"2020","unstructured":"Park J.Y.; Joo K.; Woo S.J.; Ophthalmic manifestations and genetics of the polyglutamine autosomal dominant spinocerebellar ataxias: A review. Front Neurosci  2020,14,892","journal-title":"Front Neurosci"},{"key":"ref=40","first-page":"1","author":"Storey E.","year":"2019","unstructured":"Storey E.;  Spinocerebellar Ataxia Type 15 Summary Genetic Counseling Clinical Diagnosis  2019,1-12","journal-title":"Spinocerebellar Ataxia Type 15 Summary Genetic Counseling Clinical Diagnosis"},{"key":"ref=41","first-page":"1","author":"Perlman S.","year":"2022","unstructured":"Perlman S.;  Hereditary Ataxia Overview 1  2022,1-20","journal-title":"Hereditary Ataxia Overview 1"},{"key":"ref=42","first-page":"10","author":"Anon.","year":"2012","unstructured":"Anon. ;  Inheriting Genetic Conditions Me, Help Genetics, Understand Services, Human  2012,10-11","journal-title":"Inheriting Genetic Conditions Me, Help Genetics, Understand Services, Human"},{"key":"ref=43","first-page":"1","author":"Matsuura T.","year":"2019","unstructured":"Matsuura T.; Ashizawa T.;  Spinocerebellar Ataxia Type 10 Summary Genetic Counseling Suggestive Findings  2019,1-20","journal-title":"Spinocerebellar Ataxia Type 10 Summary Genetic Counseling Suggestive Findings"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-021-01201-x","volume":"9","author":"Chintalaphani S.R.","year":"2021","unstructured":"Chintalaphani S.R.; Pineda S.S.; Deveson I.W.; Kumar K.R.; An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics. Acta Neuropathol Commun  2021,9(1),98","journal-title":"Acta Neuropathol Commun"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","volume":"35","author":"Tisdale S.","year":"2015","unstructured":"Tisdale S.; Pellizzoni L.; Disease mechanisms and therapeutic approaches in spinal muscular atrophy. J Neurosci  2015,35(23),8691-8700","journal-title":"J Neurosci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/TACG.S239603","volume":"14","author":"Tisdale S.","year":"2021","unstructured":"Tisdale S.; Pellizzoni L.; Spinal muscular atrophy: Mutations, testing, and clinical relekeinath, Melissa C. prior, devivance. Appl Clin Genet  2021,14,11-25","journal-title":"Appl Clin Genet"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/TACG.S239603","volume":"14","author":"Keinath M.C.","year":"2021","unstructured":"Keinath M.C.; Prior D.E.; Prior T.W.; Spinal muscular atrophy: Mutations, testing, and clinical relevance. Appl Clin Genet  2021,14,11-25","journal-title":"Appl Clin Genet"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmolb.2016.00007","volume":"3","author":"Butchbach M.E.R.","year":"2016","unstructured":"Butchbach M.E.R.; Copy number variations in the survival motor neuron genes: Implications for spinal muscular atrophy and other neurodegenerative diseases. Front Mol Biosci  2016,3,7","journal-title":"Front Mol Biosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/gim.2017.152","volume":"20","author":"Kraszewski J.N.","year":"2018","unstructured":"Kraszewski J.N.; Kay D.M.; Stevens C.F.; Koval C.; Haser B.; Ortiz V.; Albertorio A.; Cohen L.L.; Jain R.; Andrew S.P.; Young S.D.; LaMarca N.M.; De Vivo D.C.; Caggana M.; Chung W.K.; Pilot study of population-based newborn screening for spinal muscular atrophy in New York state. Genet Med  2018,20(6),608-613","journal-title":"Genet Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e0220211","DOI":"10.1371\/journal.pone.0220211","volume":"14","author":"Vijzelaar R.","year":"2019","unstructured":"Vijzelaar R.; Snetselaar R.; Clausen M.; Mason A.G.; Rinsma M.; Zegers M.; Molleman N.; Boschloo R.; Yilmaz R.; Kuilboer R.; Lens S.; Sulchan S.; Schouten J.; The frequency of SMN gene variants lacking exon 7 and 8 is highly population dependent. PLoS One  2019,14(7),e0220211","journal-title":"PLoS One"},{"key":"ref=51","first-page":"E80","volume":"63","author":"Niba E.T.E.","year":"2017","unstructured":"Niba E.T.E.; Ar Rochmah M.; Harahap N.I.F.; Awano H.; Morioka I.; Iijima K.; Saito T.; Saito K.; Takeuchi A.; Lai P.S.; Bouike Y.; Nishio H.; Shinohara M.; SMA diagnosis: Detection of SMN1 deletion with real-time mCOP-PCR system using fresh blood DNA. Kobe J Med Sci  2017,63(3),E80-E83","journal-title":"Kobe J Med Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/mdc3.13052","volume":"7","author":"Pellecchia M.T.","year":"2020","unstructured":"Pellecchia M.T.; Stankovic I.; Fanciulli A.; Krismer F.; Meissner W.G.; Palma J.A.; Panicker J.N.; Seppi K.; Wenning G.K.; Barone P.; Kostic V.; Sabanovic M.; Bajaj S.; Kaufmann H.; Quinn N.; Antonini A.; Bang J.; Pantelyat A.; Berardelli A.; Berg D.; Biaggioni I.; Bloem B.; Brooks D.J.; Calandra-Buonaura G.; Cortelli P.; Colosimo C.; Ferreira J.; Fox S.; Frauscher B.; Freeman R.; Fung V.; Gasser T.; Gerhard A.; Goldstein D.; Hallett M.; Halliday G.; H\u00f6glinger G.U.; Holton J.L.; Houlden H.; Iodice V.; Klockgether T.; Lang A.; Ling H.; Low P.; Litvan I.; Miki Y.; Nomura T.; Orimo S.; Ozawa T.; Postuma R.; Rascol O.; Robertson D.; Sakakibara R.; Sampaio C.; Schmahmann J.D.; Scholz S.; Senard J-M.; Sharma M.; Singer W.; Stamelou M.; Takeda A.; Tolosa E.; Tsuji S.; Vignatelli L.; Walter U.; Watanabe H.; Weintraub D.; Siebert U.; Poewe W.; Can autonomic testing and imaging contribute to the early diagnosis of multiple system atrophy? a systematic review and recommendations by the movement disorder society multiple system atrophy study group. Mov Disord Clin Pract  2020,7(7),750-762","journal-title":"Mov Disord Clin Pract"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3233\/JAD-170397","volume":"62","author":"Jellinger K.A.","year":"2018","unstructured":"Jellinger K.A.; Multiple system atrophy: An oligodendroglioneural synucleinopathy1. J Alzheimers Dis  2018,62(3),1141-1179","journal-title":"J Alzheimers Dis"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/mdc3.12404","volume":"4","author":"Kim H.J.","year":"2017","unstructured":"Kim H.J.; Jeon B.; Fung V.S.C.; Role of magnetic resonance imaging in the diagnosis of multiple system atrophy. Mov Disord Clin Pract  2017,4(1),12-20","journal-title":"Mov Disord Clin Pract"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.expneurol.2017.10.002","volume":"298","author":"Blesa J.","year":"2017","unstructured":"Blesa J.; Trigo-Damas I.; Dileone M.; del Rey N.L.G.; Hernandez L.F.; Obeso J.A.; Compensatory mechanisms in Parkinson\u2019s disease: Circuits adaptations and role in disease modification. Exp Neurol  2017,298(Pt B),148-161","journal-title":"Exp Neurol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"17329","DOI":"10.1038\/s41598-019-53980-y","volume":"9","author":"Kim M.","year":"2019","unstructured":"Kim M.; Ahn J.H.; Cho Y.; Kim J.S.; Youn J.; Cho J.W.; Differential value of brain magnetic resonance imaging in multiple system atrophy cerebellar phenotype and spinocerebellar ataxias. Sci Rep  2019,9(1),17329","journal-title":"Sci Rep"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnana.2018.00053","volume":"12","author":"Chen H.J.","year":"2018","unstructured":"Chen H.J.; Gao Y.Q.; Che C.H.; Lin H.; Ruan X.L.; Diffusion tensor imaging with tract-based spatial statistics reveals white matter abnormalities in patients with vascular cognitive impairment. Front Neuroanat  2018,12,53","journal-title":"Front Neuroanat"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"612069","DOI":"10.3389\/fneur.2020.612069","volume":"11","author":"Zhang Y.","year":"2020","unstructured":"Zhang Y.; Burock M.A.; Corrigendum: Diffusion tensor imaging in Parkinson\u2019s disease and parkinsonian syndrome: A systematic review. Front Neurol  2020,11,612069","journal-title":"Front Neurol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fneur.2020.01043","volume":"11","author":"Cao Z.","year":"2020","unstructured":"Cao Z.; Wu Y.; Liu G.; Jiang Y.; Wang X.; Wang Z.; Feng T.; Differential diagnosis of multiple system atrophy-parkinsonism and Parkinson\u2019s disease using \u03b1-synuclein and external anal sphincter electromyography. Front Neurol  2020,11,1043","journal-title":"Front Neurol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40478-019-0730-6","volume":"7","author":"Compagnoni G.M.","year":"2019","unstructured":"Compagnoni G.M.; Di Fonzo A.; Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives. Acta Neuropathol Commun  2019,7(1),113","journal-title":"Acta Neuropathol Commun"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1900360","DOI":"10.1183\/13993003.00360-2019","volume":"53","author":"Lechtzin N.","year":"2019","unstructured":"Lechtzin N.; Predicting respiratory failure in amyotrophic lateral sclerosis: recruiting a few good pulmonologists. Eur Respir J  2019,53(4),1900360","journal-title":"Eur Respir J"},{"key":"ref=62","first-page":"259","volume":"9","author":"Soiza R.L.","year":"2018","unstructured":"Soiza R.L.; Donaldson A.I.C.; Myint P.K.; Vaccine against arteriosclerosis: An update. Ther Adv Vaccines  2018,9,259-261","journal-title":"Ther Adv Vaccines"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"Masrori P.","year":"2020","unstructured":"Masrori P.; Van Damme P.; Amyotrophic lateral sclerosis: A clinical review. Eur J Neurol  2020,27(10),1918-1929","journal-title":"Eur J Neurol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00415-021-10928-5","volume":"269","author":"Re D.B.","year":"2022","unstructured":"Re D.B.; Yan B.; Calder\u00f3n-Garcidue\u00f1as L.; Andrew A.S.; Tischbein M.; Stommel E.W.; A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: Identifying exposures determining higher ALS risk. J Neurol  2022,269(5),2359-2377","journal-title":"J Neurol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/alz.12068","volume":"16","year":"2020","unstructured":"2020 Alzheimer\u2019s disease facts and figures. Alzheimers Dement  2020,16(3),391-460","journal-title":"Alzheimers Dement"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-3-319-72938-1_14","author":"Bonanni L.","year":"2018","unstructured":"Bonanni L.; Franciotti R.; Pizzi S.D.; Thomas A.; Onofrj M.;  Lewy Body Dementia NeurodegeneratIve Diseases: Clinical Aspects  2018,297-312","journal-title":"Lewy Body Dementia NeurodegeneratIve Diseases: Clinical Aspects"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"Tolosa E.","year":"2022","unstructured":"Tolosa E.; Garrido A.; Scholz S.W.; Poewe W.; Unit M.D.; Service N.; Barcelona U.; De ; Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol  2022,20,385-397","journal-title":"Lancet Neurol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"Outeiro T.F.","year":"2019","unstructured":"Outeiro T.F.; Koss D.J.; Erskine D.; Walker L.; Kurzawa-Akanbi M.; Burn D.; Donaghy P.; Morris C.; Taylor J.P.; Thomas A.; Attems J.; McKeith I.; Dementia with Lewy bodies: An update and outlook. Mol Neurodegener  2019,14(1),5","journal-title":"Mol Neurodegener"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","year":"2021","unstructured":"2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement  2021,17(3),327-406","journal-title":"Alzheimers Dement"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"Jellinger K.A.","year":"2018","unstructured":"Jellinger K.A.; Korczyn A.D.; Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med  2018,16(1),34","journal-title":"BMC Med"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40120-018-0104-1","volume":"7","author":"Capouch S.D.","year":"2018","unstructured":"Capouch S.D.; Farlow M.R.; Brosch J.R.; A review of dementia with Lewy bodies\u2019 impact, diagnostic criteria and treatment. Neurol Ther  2018,7(2),249-263","journal-title":"Neurol Ther"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2147\/TCRM.S323387","volume":"17","author":"Ruangritchankul S.","year":"2021","unstructured":"Ruangritchankul S.; Gray L.C.; Adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia\u202f: A comprehensive literature review. Ther Clin Risk Manag  2021,17,927-949","journal-title":"Ther Clin Risk Manag"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12951-022-01612-5","volume":"20","author":"Parra H.H.","year":"2022","unstructured":"Parra H.H.; Cort\u00e9s H.; Arturo J.; Fuentes A.; Del M.; Audelo P.; Flor\u00e1n B.; G\u00f3mez G.L.; Rad J.S.; Cho W.C.; Repositioning of drugs for Parkinson\u2019s disease and pharmaceutical nanotechnology tools for their optimization. J Nanobiotechnology  2022,20(1),413","journal-title":"J Nanobiotechnology"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12902-020-0507-8","volume":"20","author":"Budayr A.","year":"2020","unstructured":"Budayr A.; Tan T.C.; Lo J.C.; Zaroff J.G.; Tabada G.H.; Yang J.; Go A.S.; Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: The CATCH study. BMC Endocr Disord  2020,20(1),25","journal-title":"BMC Endocr Disord"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","volume":"211","author":"Cepeda C.","year":"2015","unstructured":"Cepeda C.; Murphy K.P.S.; Parent M.; Levine M.S.; Disabilities D.; Behavior H.; Keynes M.; City Q.; The role of dopamine in Huntington\u2019s disease. Prog Brain Res  2015,211,235-254","journal-title":"Prog Brain Res"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00001","volume":"10","author":"Sellner J.","year":"2019","unstructured":"Sellner J.; Hauer L.; Illes Z.; Warnke C.; Laurent S.; Levy M.; Immunological aspects of approved MS therapeutics. Front Immunol  2019,10,1-24","journal-title":"Front Immunol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"34725","DOI":"10.1021\/acsami.9b12319","volume":"11","author":"Cong W.","year":"2019","unstructured":"Cong W.; Bai R.; Li Y.F.; Wang L.; Chen C.; Selenium nanoparticles as an efficient nanomedicine for the therapy of Huntington\u2019s disease. ACS Appl Mater Interfaces  2019,11(38),34725-34735","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"15185","DOI":"10.1038\/s41598-021-94175-8","volume":"11","author":"Monge-Fuentes V.","year":"2021","unstructured":"Monge-Fuentes V.; Biolchi Mayer A.; Lima M.R.; Geraldes L.R.; Zanotto L.N.; Moreira K.G.; Martins O.P.; Piva H.L.; Felipe M.S.S.; Amaral A.C.; Bocca A.L.; Tedesco A.C.; Mortari M.R.; Dopamine-loaded nanoparticle systems circumvent the blood\u2013brain barrier restoring motor function in mouse model for Parkinson\u2019s disease. Sci Rep  2021,11(1),15185","journal-title":"Sci Rep"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1021\/acsbiomaterials.2c00865","volume":"8","author":"D\u00edaz-Garc\u00eda D.","year":"2022","unstructured":"D\u00edaz-Garc\u00eda D.; Ferrer-Donato \u00c1.; M\u00e9ndez-Arriaga J.M.; Cabrera-Pinto M.; D\u00edaz-S\u00e1nchez M.; Prashar S.; Fernandez-Martos C.M.; G\u00f3mez-Ruiz S.; Design of mesoporous silica nanoparticles for the treatment of amyotrophic lateral sclerosis (ALS) with a therapeutic cocktail based on leptin and pioglitazone. ACS Biomater Sci Eng  2022,8(11),4838-4849","journal-title":"ACS Biomater Sci Eng"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.smaim.2020.08.001","volume":"1","author":"Wang Z.","year":"2020","unstructured":"Wang Z.; Cheng Y.; Zhao D.; Pliss A.; Liu J.; Luan P.; Synergic treatment of Alzheimer\u2019s disease with brain targeted nanoparticles incorporating NgR-siRNA and brain derived neurotrophic factor. Smart Materials in Medicine  2020,1,125-130","journal-title":"Smart Materials in Medicine"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/ma15030804","volume":"15","author":"Bhattacharya T.","year":"2022","unstructured":"Bhattacharya T.; Soares G.A.B.; Chopra H.; Rahman M.M.; Hasan Z.; Swain S.S.; Cavalu S.; Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Materials  2022,15(3),804","journal-title":"Materials"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.3390\/ijms222111654","volume":"22","author":"Pinheiro R.G.R.","year":"2021","unstructured":"Pinheiro R.G.R.; Coutinho A.J.; Pinheiro M.; Neves A.R.; Nanoparticles for targeted brain drug delivery: What do we know? Int J Mol Sci  2021,22(21),11654","journal-title":"Int J Mol Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","volume":"13","author":"Satapathy M.K.","year":"2021","unstructured":"Satapathy M.K.; Yen T.L.; Jan J.S.; Tang R.D.; Wang J.Y.; Taliyan R.; Yang C.H.; Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB. Pharmaceutics  2021,13(8),1183","journal-title":"Pharmaceutics"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13052-018-0563-0","volume":"44","author":"Bellettato C.M.","year":"2018","unstructured":"Bellettato C.M.; Scarpa M.; Possible strategies to cross the blood\u2013brain barrier. Ital J Pediatr  2018,44(S2),131","journal-title":"Ital J Pediatr"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ajps.2018.09.005","volume":"14","author":"Niu X.","year":"2019","unstructured":"Niu X.; Chen J.; Gao J.; Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances. Asian J Pharm Sci  2019,14(5),480-496","journal-title":"Asian J Pharm Sci"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2174\/1570159X18666200831160627","volume":"19","author":"Delello L.","year":"2021","unstructured":"Delello L.; Filippo D.; Duarte J.L.; Luiz M.T.; Thayanne J.; Ara\u00fajo C.; De ; Chorilli M.; Drug delivery nanosystems in glioblastoma multiforme treatment: Current state of the art. Curr Neuropharmacol  2021,19(6),787-812","journal-title":"Curr Neuropharmacol"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2174\/1570159X18666200831160627","volume":"19","author":"Acidic G.F.","year":"2021","unstructured":"Acidic G.F.; Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current state of the Art.M Curr Neuropharmacol  2021,19(6),787-812","journal-title":"Curr Neuropharmacol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3390\/pharmaceutics14091862","volume":"14","author":"Krzyzowska M.","year":"2022","unstructured":"Krzyzowska M.; Janicka M.; Tomaszewska E.; Ranoszek-soliwoda K.; Celichowski G.; Grobelny J.; Szymanski P.; Lactoferrin-conjugated nanoparticles as new antivirals. Pharmaceutics  2022,14(9),1862","journal-title":"Pharmaceutics"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1038\/s41598-020-68874-7","volume":"10","author":"Haney M.J.","year":"2020","unstructured":"Haney M.J.; Zhao Y.; Fay J.; Duhyeong H.; Wang M.; Wang H.; Li Z.; Lee Y.Z.; Karuppan M.K.; El-Hage N.; Kabanov A.V.; Batrakova E.V.; Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X(A) mice: Importance of administration routes. Sci Rep  2020,10(1),11818","journal-title":"Sci Rep"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"Mitchell M.J.","year":"2021","unstructured":"Mitchell M.J.; Billingsley M.M.; Haley R.M.; Wechsler M.E.; Peppas N.A.; Langer R.; Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov  2021,20(2),101-124","journal-title":"Nat Rev Drug Discov"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"630055","DOI":"10.3389\/fbioe.2021.630055","volume":"9","author":"Khan N.H.","year":"2021","unstructured":"Khan N.H.; Mir M.; Ngowi E.E.; Zafar U.; Khakwani M.M.A.K.; Khattak S.; Zhai Y.K.; Jiang E.S.; Zheng M.; Duan S.F.; Wei J.S.; Wu D.D.; Ji X.Y.; Nanomedicine: A promising way to manage alzheimer\u2019s disease. Front Bioeng Biotechnol  2021,9,630055","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3389\/fphar.2019.00660","volume":"10","author":"Wang W.W.","year":"2019","unstructured":"Wang W.W.; Zhang X.R.; Lin J.Y.; Zhang Z.R.; Wang Z.; Chen S.Y.; Xie C.L.; Levodopa\/benserazide PLGA microsphere prevents l-dopa\u2013induced dyskinesia via lower \u03b2-arrestin2 in 6-hydroxydopamine Parkinson\u2019s rats. Front Pharmacol  2019,10,660","journal-title":"Front Pharmacol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","volume":"16","author":"Rahman M.M.","year":"2021","unstructured":"Rahman M.M.; Lendel C.; Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Mol Neurodegener  2021,16(1),59","journal-title":"Mol Neurodegener"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/cells12010131","volume":"12","author":"Miculas D.C.","year":"2022","unstructured":"Miculas D.C.; Negru P.A.; Bungau S.G.; Behl T.; Hassan S.S.; Tit D.M.; Pharmacotherapy evolution in Alzheimer\u2019s disease: Current framework and relevant directions. Cells  2022,12(1),131","journal-title":"Cells"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-019-0172-x","volume":"8","author":"Visanji N.P.","year":"2019","unstructured":"Visanji N.P.; Lang A.E.; Kovacs G.G.; Beyond the synucleinopathies: Alpha synuclein as a driving force in neurodegenerative comorbidities. Transl Neurodegener  2019,8(1),28","journal-title":"Transl Neurodegener"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/jpm11080720","volume":"11","author":"Mar H.","year":"2021","unstructured":"Mar H.; Widman E.; Johansson A.; Personalized medicine approach in treating Parkinson\u2019s disease, using oral administration of levodopa\/carbidopa microtablets in clinical practice. J Pers Med  2021,11(8),720","journal-title":"J Pers Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"Mahul-Mellier A.L.","year":"2020","unstructured":"Mahul-Mellier A.L.; Burtscher J.; Maharjan N.; Weerens L.; Croisier M.; Kuttler F.; Leleu M.; Knott G.W.; Lashuel H.A.; The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci  2020,117(9),4971-4982","journal-title":"Proc Natl Acad Sci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","volume":"19","author":"Taylor J.P.","year":"2020","unstructured":"Taylor J.P.; McKeith I.G.; Burn D.J.; Boeve B.F.; Weintraub D.; Bamford C.; Allan L.M.; Thomas A.J.; O\u2019Brien J.T.; New evidence on the management of Lewy body dementia. Lancet Neurol  2020,19(2),157-169","journal-title":"Lancet Neurol"},{"key":"ref=99","first-page":"1","volume":"51","author":"Lee H.J.","year":"2019","unstructured":"Lee H.J.; Ricarte D.; Ortiz D.; Lee S.J.; Models of multiple system atrophy. Exp Mol Med  2019,51(11),1-10","journal-title":"Exp Mol Med"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7759\/cureus.10741","author":"Ortiz J.F.","year":"2020","unstructured":"Ortiz J.F.; Bett\u00e9 S.; Tambo W.; Tao F.; Cozar J.C.; Isaacson S.; Multiple system atrophy \u2013 cerebellar type: clinical picture and treatment of an often-overlooked disorder. Cureus  2020,12","journal-title":"Cureus"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40478-022-01364-1","volume":"10","author":"Hickman R.A.","year":"2022","unstructured":"Hickman R.A.; Faust P.L.; Marder K.; Yamamoto A.; Vonsattel J.P.; The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade. Acta Neuropathol Commun  2022,10(1),55","journal-title":"Acta Neuropathol Commun"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40120-021-00309-5","volume":"11","author":"Claassen D.O.","year":"2022","unstructured":"Claassen D.O.; Ayyagari R.; Garcia-Horton V.; Zhang S.; Alexander J.; Leo S.; Real-world adherence to tetrabenazine or deutetrabenazine among patients with Huntington\u2019s disease: A retrospective database analysis. Neurol Ther  2022,11(1),435-448","journal-title":"Neurol Ther"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"Suk T.R.","year":"2020","unstructured":"Suk T.R.; Rousseaux M.W.C.; The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener  2020,15(1),45","journal-title":"Mol Neurodegener"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40035-021-00250-5","volume":"10","author":"Xu X.","year":"2021","unstructured":"Xu X.; Shen D.; Gao Y.; Zhou Q.; Ni Y.; Meng H.; Shi H.; Le W.; Chen S.; Chen S.; A perspective on therapies for amyotrophic lateral sclerosis: Can disease progression be curbed? Transl Neurodegener  2021,10(1),29","journal-title":"Transl Neurodegener"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230403085733","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215389\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230403085733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T14:57:29Z","timestamp":1714748249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215389\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":104,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666230403085733","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-11-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}